tiprankstipranks
Trending News
More News >
Noxopharm Secures $2.5 Million for Clinical Trials and R&D
PremiumCompany AnnouncementsNoxopharm Secures $2.5 Million for Clinical Trials and R&D
2M ago
Noxopharm Unveils Promising SOF-SKN Data at Rheumatology Conference
Premium
Company Announcements
Noxopharm Unveils Promising SOF-SKN Data at Rheumatology Conference
2M ago
Noxopharm Advances SOF-SKN™ to First Human Trials in Australia
Premium
Company Announcements
Noxopharm Advances SOF-SKN™ to First Human Trials in Australia
2M ago
Noxopharm Reports Half-Year Financial Results and Strategic Focus
PremiumCompany AnnouncementsNoxopharm Reports Half-Year Financial Results and Strategic Focus
4M ago
Noxopharm’s SOF-SKN™ Passes Key Safety Tests Ahead of Clinical Trials
Premium
Company Announcements
Noxopharm’s SOF-SKN™ Passes Key Safety Tests Ahead of Clinical Trials
5M ago
Noxopharm Ltd. Issues Convertible Notes to Enhance Capital Structure
Premium
Company Announcements
Noxopharm Ltd. Issues Convertible Notes to Enhance Capital Structure
6M ago
Noxopharm Achieves Key Approvals at Annual Meeting
PremiumCompany AnnouncementsNoxopharm Achieves Key Approvals at Annual Meeting
8M ago
Noxopharm Unveils Strategic Advances and Market Prospects
Premium
Company Announcements
Noxopharm Unveils Strategic Advances and Market Prospects
8M ago
Noxopharm Advances in Biotech with Promising Developments
Premium
Company Announcements
Noxopharm Advances in Biotech with Promising Developments
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100